Mauro Novelli

The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells

M.G. Bernengo, Mauro Novelli, Pietro Quaglino et al. · British Journal of Dermatology · 2001 · 199 citations

Low-dose intermittent alemtuzumab in the treatment of Sezary syndrome: clinical and immunologic findings in 14 patients

Maria Grazia Bernengo, Pietro Quaglino, Alessandra Comessatti et al. · Haematologica · 2007 · 175 citations · Full text

T-cell receptor γ gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and i

Renata Ponti, Pietro Quaglino, Mauro Novelli et al. · British Journal of Dermatology · 2005 · 123 citations

Prognostic factors in Sézary syndrome: A multivariate analysis of clinical, haematological and immunological features

M.G. Bernengo, Pietro Quaglino, Mauro Novelli et al. · Annals of Oncology · 1998 · 115 citations

Prognostic Factors, Sézary Syndrome, Immunodeficiencies +7

Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response

Pietro Quaglino, Massimiliano Bergallo, Renata Ponti et al. · Dermatology · 2011 · 87 citations · Full text